15th Congress of the European Hematology Association
Webcasted Presentation

Search’n Build™

Risk adapted treatment

Keith Stewart
Keith Stewart
United States of America  
Disclosure : Millenium: Consultant, honorarium, research funding.
Celgene: Honorarium
[More] [Less]
Topic: Other
49 slide(s) – 00:23:44 – English – 2010-06-11
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
A A A  
After this presentation the participant will be able to discuss:

- Genetic events resulting in Myeloma.
- Effects of genetics events on prognosis.
- Ability of new drugs to overcome high risk genetics.
- Synthesizing genetic information in treatment planning.
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.